Lantern Pharma Inc. Effective Income Tax Rate Reconciliation, Deduction, Percent
Lantern Pharma Inc. (LTRN) reported Effective Income Tax Rate Reconciliation, Deduction, Percent of 1.00% for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-10.
Discontinued › Expense Statement
us-gaap:EffectiveIncomeTaxRateReconciliationDeductions · last filed 2021-03-10
- Lantern Pharma Inc. effective income tax rate reconciliation, deduction, percent for fiscal 2020 was 1.00%.
- Lantern Pharma Inc. effective income tax rate reconciliation, deduction, percent for fiscal 2019 was -1.00%.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Percent 12 month |
|---|---|
| 2020-12-31 | 1.00% 10-K · filed 2021-03-10 |
| 2019-12-31 | -1.00% 10-K · filed 2021-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |